Scientists have developed flavonoid-based, organic carbon monoxide-releasing molecules that exhibit CO release only when triggered by visible light. Using fluorescence microscopy, the researchers demonstrate targeted CO delivery by the photoCORMs to human lung cancer cells, as well as the ability of the molecules to produce anti-inflammatory effects.